FFP
ABBV icon

FourThought Financial Partners’s AbbVie ABBV Stock Holding History

FourThought Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Buy
17,032
+404
+2% +$86.9K 0.33% 79
2026
Q1 		$3.62M Sell
16,628
-612
-4% -$136K 0.31% 84
2025
Q4 		$3.94M Buy
17,240
+215
+1% +$49K 0.33% 74
2025
Q3 		$3.94M Sell
17,025
-281
-2% -$57.2K 0.35% 75
2025
Q2 		$3.21M Sell
17,306
-531
-3% -$98.7K 0.32% 82
2025
Q1 		$3.74M Sell
17,837
-184
-1% -$35.8K 0.39% 73
2024
Q4 		$3.2M Buy
+18,021
New +$3.31M 0.33% 78
2024
Q2 		– Sell
-18,205
Closed -$3.32M – 179
2024
Q1 		$3.32M Sell
18,205
-45
-0.2% -$7.75K 0.38% 66
2023
Q4 		$2.83M Buy
18,250
+33
+0.2% +$4.81K 0.35% 72
2023
Q3 		$2.72M Buy
18,217
+802
+5% +$118K 0.38% 67
2023
Q2 		$2.35M Sell
17,415
-380
-2% -$55.7K 0.31% 82
2023
Q1 		$2.84M Buy
17,795
+30
+0.2% +$4.59K 0.39% 72
2022
Q4 		$2.87M Buy
+17,765
New +$2.72M 0.42% 68

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FourThought Financial Partners's ABBV Position: Q2 2026 in Review

FourThought Financial Partners increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $86.9K and bringing the position to 17,032 shares worth $4.29M. The position accounts for 0.33% of the portfolio, ranked #79.

FourThought Financial Partners first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • FourThought Financial Partners held 17,032 shares of AbbVie worth $4.29M as of Q2 2026.
  • FourThought Financial Partners bought 404 AbbVie shares in Q2 2026, an estimated $86.9K.
  • AbbVie made up 0.33% of FourThought Financial Partners's portfolio in Q2 2026, its #79 holding.
  • FourThought Financial Partners first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.